Utah Medical Products, Inc.
UTMD
$52.30
-$0.10-0.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.55% | 3.19% | -12.71% | -7.70% | 8.92% |
| Total Depreciation and Amortization | -1.35% | 6.78% | 1.46% | -34.33% | -41.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 100.00% | 4.46% | 66.96% | -253.13% |
| Change in Net Operating Assets | -85.23% | 65.00% | -270.49% | 117.10% | 168.59% |
| Cash from Operations | -23.83% | 39.61% | -47.65% | -1.05% | 4.12% |
| Capital Expenditure | 89.89% | 19.09% | -400.00% | 75.56% | 51.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | 89.89% | 22.61% | -2,400.00% | 105.56% | 51.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 206.25% | -- | -100.00% |
| Repurchase of Common Stock | -73.54% | 39.62% | -114.15% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.33% | 2.68% | 0.73% | -1.68% | 0.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.52% | 31.60% | -80.52% | -271.90% | -3.48% |
| Foreign Exchange rate Adjustments | -271.09% | 934.78% | 87.15% | -173.36% | 257.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -613.95% | 83.29% | -588.19% | -79.82% | 29.78% |